Page last updated: 2024-09-04

aclacinomycin and Graft-Versus-Host Disease

aclacinomycin has been researched along with Graft-Versus-Host Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Bo, J; Dou, L; Gao, C; Gao, X; Li, H; Liu, D; Lu, N; Wang, L; Wei, Y; Wu, Y; Zhang, R; Zhu, C1
Dickneite, G; Kurrle, R; Sedlacek, HH; Seiler, FR1

Trials

1 trial(s) available for aclacinomycin and Graft-Versus-Host Disease

ArticleYear
A phase II study of chidamide, cytarabine, aclarubicin, granulocyte colony-stimulating factor, and donor lymphocyte infusion for relapsed acute myeloid leukemia and myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation.
    Medical oncology (Northwood, London, England), 2023, Jan-10, Volume: 40, Issue:2

    Topics: Aclarubicin; Adult; Cytarabine; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Lymphocytes; Myelodysplastic Syndromes; Recurrence

2023

Other Studies

1 other study(ies) available for aclacinomycin and Graft-Versus-Host Disease

ArticleYear
Immunosuppression as a desired pharmacological effect.
    Behring Institute Mitteilungen, 1984, Issue:74

    Topics: Aclarubicin; Anemia, Hemolytic; Animals; Antibiotics, Antineoplastic; Antibody Formation; Encephalomyelitis, Autoimmune, Experimental; Female; Glomerulonephritis; Graft vs Host Disease; Hemolytic Plaque Technique; Immune Complex Diseases; Immunity, Cellular; Immunosuppressive Agents; Mice; Mice, Inbred Strains; Naphthacenes; Rats; Rats, Inbred Lew

1984